PI3Kbeta regulates macropinocytosis in PTEN-null tumor cells

被引：0
|
作者：
Salloum, Gilbert [1 ]
Jakubik, Charles [1 ]
Bresnick, Anne R. [1 ]
Backer, Jonathan M. [1 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-3431
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3431
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment
    Qi, Zhi
    Xu, Zihan
    Zhang, Liuzhen
    Zou, Yongkang
    Li, Jinping
    Yan, Wenyu
    Li, Cheng
    Liu, Ningshu
    Wu, Hong
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [22] Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment
    Zhi Qi
    Zihan Xu
    Liuzhen Zhang
    Yongkang Zou
    Jinping Li
    Wenyu Yan
    Cheng Li
    Ningshu Liu
    Hong Wu
    [J]. Nature Communications, 13
  • [23] Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer
    Allott, Emma H.
    Masko, Elizabeth M.
    Freedland, Alexis R.
    Macias, Everardo
    Pelton, Kristine
    Solomon, Keith R.
    Mostaghel, Elahe A.
    Thomas, George, V
    Pizzo, Salvatore, V
    Freeman, Michael R.
    Freedland, Stephen J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (02) : 196 - 203
  • [24] Curcumin monoglucuronide modulates the tumor microenvironment of Pten-null prostate tumors and exhibits antitumor activity
    Kura, Yurie
    De Velasco, Marco A.
    Ando, Naomi
    Sakai, Kazuko
    Fujita, Kazutoshi
    Banno, Eri
    Fujita, Yoshihiko
    Hashimoto, Mamoru
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [25] Curcumin monoglucuronide modulates tumor microenvironment of Pten-null prostate tumors and exhibits antitumor activity
    Kura, Yurie
    Develasco, Marco A.
    Sakai, Kazuko
    Fujita, Yoshihiko
    Hashimoto, Mamoru
    Mori, Yasunori
    Minami, Takafumi
    Fujita, Kazutoshi
    Kakeya, Hideaki
    Uemura, Hirotsugu
    Nishio, Kazuto
    [J]. CANCER SCIENCE, 2022, 113 : 1413 - 1413
  • [26] Expansion of Hepatic Tumor Progenitor Cells in Pten-Null Mice Requires Liver Injury and Is Reversed by Loss of AKT2
    Galicia, Vivian A.
    He, Lina
    Dang, Hien
    Kanel, Gary
    Vendryes, Christopher
    French, Barbara A.
    Zeng, Ni
    Bayan, Jennifer-Ann
    Ding, Wei
    Wang, Kasper S.
    French, Samuel
    Birnbaum, Morris J.
    Rountree, C. Bart
    Stiles, Bangyan L.
    [J]. GASTROENTEROLOGY, 2010, 139 (06) : 2170 - 2182
  • [27] Bipotential progenitor cells give rise to hepatocellular carcinoma in liver specific Pten-null mice
    Galicia, Vivian
    Stiles, Bangyan
    [J]. CANCER RESEARCH, 2009, 69
  • [28] Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3′-kinase/Akt pathway signaling
    She, QB
    Solit, D
    Basso, A
    Moasser, MM
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (12) : 4340 - 4346
  • [29] PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
    Fang, Jing
    Ding, Min
    Yang, Lily
    Liu, Ling-Zhi
    Jiang, Bing-Hua
    [J]. CELLULAR SIGNALLING, 2007, 19 (12) : 2487 - 2497
  • [30] Lin-Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model
    Mulholland, David J.
    Xin, Li
    Morim, Ashkan
    Lawson, Devon
    Witte, Owen
    Wu, Hong
    [J]. CANCER RESEARCH, 2009, 69 (22) : 8555 - 8562
12345